Business
– Acting CEO Eyal Desheh: We are committed to reducing costs by $2 billion and moving production from the US to Europe and Asia....
Hi, what are you looking for?
– Acting CEO Eyal Desheh: We are committed to reducing costs by $2 billion and moving production from the US to Europe and Asia....
– – Teva Pharmaceutical Industries Ltd (NYSE:TEVA) today announced that Erez Vigodman, 54, has been appointed President and Chief Executive Officer, effective February 11,...
– In an email to investors seen by the “Financial Times, ” printing pioneer Benny Landa hints he is seeking to oust Teva chairman...
– Can-Fite CEO Pnina Fishman: The fact that the safety profile of CF101 remains high is encouraging. – CEO Pnina Fishman / Ilan Besor...
– Takeda Israel Ltd. will be headquartered in the Tel Aviv area and will market products with an initial focus on oncology. – Takeda...
– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal...
– Given Imaging CEO: After thoroughly evaluating our options we determined that this deal is in the best interests of Given Imaging. – Irish...
Anne Wojcicki/ Getty – Last week Jewish Business News reported : on a battle that, California based, online genetic testing company 23andMe has found...
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company Limited ((TSE: 4502) today announced the signing earlier this year of an agreement in...
– The Company’s VB-111 is a gene therapy for prolonging the survival in patients with recurrent Glioblastoma Multiforme (rGBM), an aggressive form of brain...